Emergent BioSolutions (EBS) Inventory (2010 - 2026)
Emergent BioSolutions (EBS) posted quarterly Inventory of $327.6 million for Q1 2026, up 4.33% year-over-year from $314.0 million in Q1 2025, and down 4.6% quarter-over-quarter from $343.4 million in Q4 2025.
Emergent BioSolutions (EBS) Inventory (2010 - 2026) Analysis & Trends
Emergent BioSolutions' Inventory history runs 17 years deep, the most recent figure standing at $327.6 million for Q1 2026.
- In Q1 2026, Inventory rose 4.33% year-over-year to $327.6 million; the TTM figure through Mar 2026 stood at $327.6 million (up 4.33% YoY), while the FY2025 annual figure was $343.4 million, up 10.17% from the prior year.
- Inventory for Q1 2026 stood at $327.6 million, down from $343.4 million in the prior quarter.
- The five-year high for Inventory was $528.2 million in Q3 2022, with the low at $311.7 million in Q4 2024.
- The 5-year median for Inventory is $343.4 million (2025), against an average of $357.4 million.
- The sharpest annual moves came in 2022 and 2023: Inventory soared 44.87% in 2022, then sank 32.96% in 2023.
- Emergent BioSolutions' Inventory stood at $350.7 million in 2022, then slipped by 6.22% to $328.9 million in 2023, then retreated by 5.23% to $311.7 million in 2024, then gained by 10.17% to $343.4 million in 2025, then retreated by 4.6% to $327.6 million in 2026.
- Business Quant data shows EBS's Inventory at $327.6 million in Q1 2026, $343.4 million in Q4 2025, and $356.3 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Inventory (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.83 Bn | 42.86 Bn | - | 1.44 Bn |
| 2 | Teva Pharmaceutical Industries | 42.87 Bn | 39.22 Bn | 2.15 Bn | 3.22 Bn |
| 3 | Zoetis | 31.41 Bn | 29.73 Bn | 1.05 Bn | 2.57 Bn |
| 4 | Takeda Pharmaceutical | 28.55 Bn | 22.75 Bn | 5.10 Bn | 9.08 Bn |
| 5 | United Therapeutics | 22.08 Bn | 19.42 Bn | 683.80 Mn | 193.80 Mn |
| 6 | Viatris | 18.73 Bn | 17.84 Bn | 1.46 Bn | 3.93 Bn |
| 7 | Neurocrine Biosciences | 15.44 Bn | 15.05 Bn | 935.80 Mn | 104.20 Mn |
| 8 | Elanco Animal Health | 11.75 Bn | 11.22 Bn | 798.00 Mn | 1.77 Bn |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.94 Bn | - | 816.00 Mn |
| 10 | Emergent BioSolutions | 251.81 Mn | 110.91 Mn | 137.20 Mn | 303.60 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 303.60 Mn |
| Mar 31, 2026 | 327.60 Mn |
| Dec 31, 2025 | 343.40 Mn |
| Sep 30, 2025 | 356.30 Mn |
| Jun 30, 2025 | 338.60 Mn |
| Mar 31, 2025 | 314.00 Mn |
| Dec 31, 2024 | 311.70 Mn |
| Sep 30, 2024 | 322.70 Mn |
| Jun 30, 2024 | 317.50 Mn |
| Mar 31, 2024 | 333.40 Mn |
| Dec 31, 2023 | 328.90 Mn |
| Sep 30, 2023 | 354.10 Mn |
| Jun 30, 2023 | 354.30 Mn |
| Mar 31, 2023 | 367.90 Mn |
| Dec 31, 2022 | 350.70 Mn |
| Sep 30, 2022 | 528.20 Mn |
| Jun 30, 2022 | 425.50 Mn |
| Mar 31, 2022 | 400.70 Mn |
| Dec 31, 2021 | 344.50 Mn |
| Sep 30, 2021 | 364.60 Mn |